Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extracorporeal Membrane Oxygenation (ECMO) as a Therapeutic Option in Severe Form of COVID-19: a Nationwide Cohort Study

NCT04397588 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT04397588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extracorporeal Membrane Oxygenation (ECMO) as a Therapeutic Option in Severe Form of COVID-19: a Nationwide Cohort Study
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
April 21, 2020
Completion date
May 24, 2022
Enrollment
761 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

acute refractory heart failure related to sars-cov 2, ards related to severe acute respiratory syndrome-coronavirus (sars-cov) 2